Next Oncology — Dallas, Texas

Next Oncology is a clinical research site located in Dallas, Texas, United States 75039.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Next Oncology has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor, Adult, Refractory Tumor, Breast Cancer.

Sponsors: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company, Incyclix Bio.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Next Oncology?

Next Oncology has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Next Oncology conducted?

Next Oncology has 2 clinical trials on record, with 1 currently active. Their work covers Solid Tumor, Adult, Refractory Tumor, Breast Cancer.

Is Next Oncology accredited by Crixeo Health?

Next Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Next Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.